Glypican-1 is expressed in glioma endothelial blood vessels, but undetectable in healthy brain endothelial blood vessels, and enhanced the mitogenic activity of FGF2-FGFR1-IgIIIc signaling [246]. The gene discussed is FGF2; the disease is central nervous system cancer.